Login to Your Account



Biogen's shares take a hit on lackluster sales of Tecfidera

By Peter Winter
BioWorld Insight Editor

Friday, April 24, 2015
It was a mixed start for the year for Biogen Inc. While making good progress on the pipeline, according to CEO George Scangos the firm's commercial results were not as strong as execs would have hoped.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription